Modular multi-source prediction of drug side-effects with DruGNN
Pietro Bongini, Franco Scarselli, Monica Bianchini, Giovanna Maria, Dimitri, Niccol\`o Pancino, Pietro Li\`o

TL;DR
This paper introduces DruGNN, a graph neural network model that integrates heterogeneous biological data into a graph to predict drug side-effects, aiming to improve early detection and reduce costs in drug development.
Contribution
The work presents a novel graph dataset representing relational biological data and applies GNNs for drug side-effect prediction, highlighting the importance of data relationships.
Findings
Relational graph data improves prediction accuracy.
Certain data subsets are crucial for identifying drug-side effect associations.
GNNs outperform traditional models in this task.
Abstract
Drug Side-Effects (DSEs) have a high impact on public health, care system costs, and drug discovery processes. Predicting the probability of side-effects, before their occurrence, is fundamental to reduce this impact, in particular on drug discovery. Candidate molecules could be screened before undergoing clinical trials, reducing the costs in time, money, and health of the participants. Drug side-effects are triggered by complex biological processes involving many different entities, from drug structures to protein-protein interactions. To predict their occurrence, it is necessary to integrate data from heterogeneous sources. In this work, such heterogeneous data is integrated into a graph dataset, expressively representing the relational information between different entities, such as drug molecules and genes. The relational nature of the dataset represents an important novelty for…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsComputational Drug Discovery Methods · Pharmacogenetics and Drug Metabolism · Machine Learning in Materials Science
